Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13951742 | 0.71 | ALDH1A1 (0.40) | NISCHMEN1ALDH1A1POLBKMT2A | |
| SCHEMBL17952209 | 0.68 | CYP1A2 (0.33) | MEN1ALDH1A1POLBKMT2A | |
| SCHEMBL13875971 | 0.67 | HTR2C (0.35) | — | |
| SCHEMBL9891022 | 0.67 | ALDH1A1 (0.36) | MEN1ALDH1A1POLBKMT2A | |
| SCHEMBL12083455 | 0.67 | ALDH1A1 (0.36) | MEN1ALDH1A1POLBKMT2A | |
| SCHEMBL16709143 | 0.66 | ALOX12 (0.40) | — | |
| SCHEMBL11527828 | 0.63 | NISCH (0.40) | NISCHMEN1ALDH1A1POLBKMT2A | |
| SCHEMBL10506604 | 0.59 | — | — | |
| SCHEMBL3424465 | 0.59 | AHR (0.44) | ALDH1A1 | |
| SCHEMBL25100822 | 0.59 | CYP2A6 (0.36) | MEN1ALDH1A1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8877937-B2 | Process for preparing transition metal-carbene complexes | BASF SE (DE) | 2014-11-04 | — | — | US | disclosed |
| US-20130178621-A1 | PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES | BASF SE (DE) | 2013-07-11 | — | — | US | disclosed |
| US-8410280-B2 | Process for preparing transition metal-carbene complexes | BASF SE (DE) | 2013-04-02 | — | — | US | disclosed |
| US-20090018330-A1 | PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES | BASF SE (DE) | 2009-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018330-A1 | PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES | AP1M1, C1S, GPS1 | NISCH 3645/4885MEN1 51/4885ALDH1A1 2893/4885 |
| US-20130178621-A1 | PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES | AP1M1, C1S, GPS1 | NISCH 3645/4885MEN1 51/4885ALDH1A1 2893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.